162 related articles for article (PubMed ID: 38698370)
1. F. Nucleatum enhances oral squamous cell carcinoma proliferation via E-cadherin/β-Catenin pathway.
Li Z; Liu Y; Huang X; Wang Q; Fu R; Wen X; Liu J; Zhang L
BMC Oral Health; 2024 May; 24(1):518. PubMed ID: 38698370
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
3.
Geng F; Zhang Y; Lu Z; Zhang S; Pan Y
DNA Cell Biol; 2020 Jan; 39(1):144-151. PubMed ID: 31765243
[TBL] [Abstract][Full Text] [Related]
4. Localization of Fusobacterium nucleatum in oral squamous cell carcinoma and its possible directly interacting protein molecules: A case series.
He X; Ma X; Meng Z; Han Z; Chen W
Histol Histopathol; 2023 Aug; 38(8):929-939. PubMed ID: 36478348
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
6. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum.
Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T
Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225
[TBL] [Abstract][Full Text] [Related]
8. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells.
Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y
Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795
[TBL] [Abstract][Full Text] [Related]
9. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
10. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA.
Jiang Y; Huang Y; Hu Y; Yang Y; You F; Hu Q; Li X; Zhao Z
J Ethnopharmacol; 2024 Jun; 328():117932. PubMed ID: 38382652
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.
Kaur J; Sawhney M; DattaGupta S; Shukla NK; Srivastava A; Walfish PG; Ralhan R
PLoS One; 2013; 8(6):e67361. PubMed ID: 23840677
[TBL] [Abstract][Full Text] [Related]
12. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
[TBL] [Abstract][Full Text] [Related]
13. CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity.
Sakurai K; Tomihara K; Yamazaki M; Heshiki W; Moniruzzaman R; Sekido K; Tachinami H; Ikeda A; Imaue S; Fujiwara K; Noguchi M
Oral Dis; 2020 May; 26(4):745-755. PubMed ID: 31603606
[TBL] [Abstract][Full Text] [Related]
14. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
15. Quercetin suppresses the tumorigenesis of oral squamous cell carcinoma by regulating microRNA-22/WNT1/β-catenin axis.
Zhang C; Hao Y; Sun Y; Liu P
J Pharmacol Sci; 2019 Jun; 140(2):128-136. PubMed ID: 31257059
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
18. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.
Nomoto D; Baba Y; Liu Y; Tsutsuki H; Okadome K; Harada K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Moroishi T; Komohara Y; Sawa T; Baba H
Cancer Lett; 2022 Apr; 530():59-67. PubMed ID: 35033591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
